Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2014 Feb 12;23(5):725–734. doi: 10.1158/1055-9965.EPI-13-1017
Clinical Subtype Population N Sampled N Sample
Fraction 		Extra
Cases N 		Subcohort
After
Exclusions 		Extra Cases
After
Exclusions 		Analytic
Sample
ER+ or PR+, Her2- 3018 500 18% 467 435 372
ER+ or PR+, Her2+ 439 439 100% 343
ER-, PR-,Her2- 505 505 100% 405
ER-, PR-, Her2+ 177 177 100% 136
Totals 4139 1621 467 1319 372 1691